Difficulty: Medium
Average Score: 94%
Practice
As the physician, you could tell the patient (and close family members) all of the following things about levodopa except?
Correct answer
D
Rationale
In this scenario, the correct answer is D) A net-like reddish to blue discoloration of the skin is a likely side effect of the medication. Levodopa is a medication commonly used to treat Parkinson's disease, and while it can have various side effects, skin discoloration is not one of them.
Option A is incorrect because taking the drug in divided doses can indeed help decrease nausea and vomiting, as it can reduce the intensity of these side effects. Option B is incorrect because levodopa can cause orthostatic hypotension, which may lead to dizziness upon standing up due to a sudden drop in blood pressure. Option C is incorrect because levodopa can cause dyskinesias, which are characterized by involuntary muscle movements, not uncontrollable muscle jerks.
Educationally, understanding the side effects and proper administration of medications like levodopa is crucial for healthcare professionals. By knowing the correct information, healthcare providers can educate patients and their families effectively, ensuring safe and optimal treatment outcomes for individuals with Parkinson's disease.
Option A is incorrect because taking the drug in divided doses can indeed help decrease nausea and vomiting, as it can reduce the intensity of these side effects. Option B is incorrect because levodopa can cause orthostatic hypotension, which may lead to dizziness upon standing up due to a sudden drop in blood pressure. Option C is incorrect because levodopa can cause dyskinesias, which are characterized by involuntary muscle movements, not uncontrollable muscle jerks.
Educationally, understanding the side effects and proper administration of medications like levodopa is crucial for healthcare professionals. By knowing the correct information, healthcare providers can educate patients and their families effectively, ensuring safe and optimal treatment outcomes for individuals with Parkinson's disease.